ZIMLAB

Zim Laboratories Share PriceZim Laboratories

₹113.1
-1.25 (-1.09%)
As on 04 December, 2023 | 21:48 BSE: 541400 NSE: ZIMLABISIN: INE518E01015

Zim Laboratories Performance

Day Range

  • Low 112.50
  • High 116.40
₹ 113.1

52 Week Range

  • Low 68.05
  • High 152.70
₹ 113.1
  • Open Price115.30
  • Previous Close114.70
  • Volume189799

Start SIP in Zim Laboratories

Start SIP

Zim Laboratories Share Price

  • Over 1 Month -8.94%
  • Over 3 Month -11.88%
  • Over 6 Month 5.91%
  • Over 1 Year 4.69%

Zim Laboratories Key Statistics

P/E Ratio 30.3
PEG Ratio -1.9
Market Cap Cr 551
Price to Book Ratio 2.8
EPS 5.1
Dividend 0
Relative Strength Index 40.3
Money Flow Index 42.94
MACD Signal -0.69
Average True Range 3.79

Zim Laboratories Investment Rating

  • Master Rating:
  • Zim Laboratories has an operating revenue of Rs. 359.65 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 9% is okay, ROE of 12% is good. The company has a reasonable debt to equity of 12%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 9% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 35 which is a POOR score indicating inconsistency in earnings, a RS Rating of 34 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 64 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Zim Laboratories Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 85671041009993104
Operating Expenses Qtr Cr 76628988878190
Operating Profit Qtr Cr 951513121114
Depreciation Qtr Cr 4454444
Interest Qtr Cr 1212111
Tax Qtr Cr 1033324
Net Profit Qtr Cr 4077666
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 403334
Operating Expenses Annual Cr 345292
Operating Profit Annual in Cr 5138
Depreciation Cr 1615
Interest Annual Cr 68
Tax Annual Cr 116
Net Profit Annual Cr 2513
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 3547
Cash from Investing Activity Annual Cr -35-14
Cash from Financing Annual Activity Cr 1-33
Net Cash Flow Annual Cr 10
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 194170
Fixed Assets Annual Cr 133115
Total Non Current Assets Annual Cr 156135
Total Current Assets Annual Cr 179201
Total Assets Annual Cr 335335
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 40105
ROE Annual % 138
ROCE Annual % 1815
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1513
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 86671051019993105
Operating Expenses Qtr Cr 77639088878290
Operating Profit Qtr Cr 951513121115
Depreciation Qtr Cr 4454444
Interest Qtr Cr 1212111
Tax Qtr Cr 1033324
Net Profit Qtr Cr 4077557
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 405338
Operating Expenses Annual Cr 347292
Operating Profit Annual in Cr 5241
Depreciation Cr 1716
Interest Annual Cr 68
Tax Annual Cr 116
Net Profit Annual Cr 2415
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 3849
Cash from Investing Activity Annual Cr -36-15
Cash from Financing Annual Activity Cr 1-33
Net Cash Flow Annual Cr 22
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 200176
Fixed Assets Annual Cr 135117
Total Non Current Assets Annual Cr 151129
Total Current Assets Annual Cr 191212
Total Assets Annual Cr 342342
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 41108
ROE Annual % 128
ROCE Annual % 1815
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1514

Zim Laboratories Technicals

EMA & SMA

Current Price
₹113.1
-1.25 (-1.09%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹116.81
  • 50 Day
  • ₹118.04
  • 100 Day
  • ₹116.37
  • 200 Day
  • ₹109.07
  • 20 Day
  • ₹117.79
  • 50 Day
  • ₹118.20
  • 100 Day
  • ₹120.92
  • 200 Day
  • ₹105.39

Zim Laboratories Resistance and Support

PIVOT
₹114.34
Resistance
First Resistance 115.67
Second Resistance 117.73
Third Resistance 119.07
RSI 40.30
MFI 42.94
MACD Single Line -0.69
MACD -1.12
Support
First Resistance 112.27
Second Resistance 110.93
Third Resistance 108.87

Zim Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 198,078 12,130,297 61.24
Week 136,843 7,969,736 58.24
1 Month 189,698 10,581,366 55.78
6 Month 566,800 28,249,290 49.84

Zim Laboratories Result Highlights

Zim Laboratories Synopsis

NSE-Medical-Generic Drugs

Zim Laboratories is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 396.53 Cr. and Equity Capital is Rs. 48.73 Cr. for the Year ended 31/03/2023. Zim Laboratories Ltd. is a Public Limited Listed company incorporated on 14/02/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1984PLC032172 and registration number is 032172.
Market Cap 552
Sales 357
Shares in Float 3.26
No of funds 3
Yield
Book Value 2.88
U/D Vol ratio 0.8
LTDebt / Equity 13
Alpha 0.04
Beta 0.91

Zim Laboratories

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 33.26%33.26%33.26%33.26%
Foreign Portfolio Investors 0.06%
Individual Investors 50.75%49.9%51.58%51.57%
Others 15.99%16.78%15.16%15.17%

Zim Laboratories Management

Name Designation
Dr. Anwar Daud Chairman & Managing Director
Mr. Prakash Sapkal Executive Director
Mr. Niraj Dhadiwal Executive Director
Mr. Zulfiquar M Kamal Director - Finance
Dr. Kakasaheb Mahadik Independent Director
Mrs. Kavita Loya Independent Director
Mr. Padmakar Joshi Independent Director
Dr. Kamlesh Shende Independent Director

Zim Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Zim Laboratories Corporate Action

Date Purpose Remarks
2023-11-01 Quarterly Results
2023-08-14 Quarterly Results
2023-05-19 Audited Results
2023-02-03 Quarterly Results
2022-11-12 Quarterly Results & Bonus issue
Date Purpose Remarks
2022-12-22 Bonus Rs.0.00 issue in the ratio of 2:1 of Rs. 10/-

Zim Laboratories FAQs

What is Share Price of Zim Laboratories ?

Zim Laboratories share price is ₹113 As on 04 December, 2023 | 21:34

What is the Market Cap of Zim Laboratories ?

The Market Cap of Zim Laboratories is ₹551.1 Cr As on 04 December, 2023 | 21:34

What is the P/E ratio of Zim Laboratories ?

The P/E ratio of Zim Laboratories is 30.3 As on 04 December, 2023 | 21:34

What is the PB ratio of Zim Laboratories ?

The PB ratio of Zim Laboratories is 2.8 As on 04 December, 2023 | 21:34

Q2FY23